• 2001-2021
    KEEP LIFE FLOWING

    Learn more

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • WATCH THE INTERVIEW

    In keeping with Kedrion’s continuing commitment to divulge precise medical-scientific information, Andrea Caricasole, Head of Research & Innovation, tackles the topic of anti Covid treatment based on monoclonal and polyclonal antibodies.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

18-10-2021
Kedrion grows in North America as it completes acquisition of Prometic
Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficiency
Read all
14-10-2021
Kedrion Biopharma expands its commitment in Turkey
Expansion plans revealed at Embassy reception in Ankara on October 14
Read all
04-10-2021
4ID – Kedrion proud to support new App for patients with Immunodeficiencies
Our company restates its long-standing and consistent collaboration with IPOPI
Read all
2020 Annual report
Pharmacovigilance
Medical & Scientific Information
VIDEO-GALLERY